Jim Cramer Talked About These 16 Stocks and Market Froth
Tonight, we are going to talk about something I despise.
Novo Nordisk A S (NVO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 75,000 | $3,816 | 1.11% | |
| 2. | Hourglass Capital Kenneth A. Moffet | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,206,819 | $112,529,610 | 0.6% | |
| 2. | 614,866 | $31,284,382 | 0.05% | |
| 3. | 426,700 | $21,710,496 | 2% | |
| 4. | 402,133 | $20,460,542 | 1.09% | |
| 5. | 342,482 | $17,425,508 | 0.2% |
News See All
Novo Nordisk (NVO) is "in a Battle," Says Jim Cramer
Pharma giant Novo Nordisk A/S (NYSE:NVO) created quite the buzz last month after its weight loss pill secured approval from the Food and Drug Administration (FDA), following which the shares jumped by...
10 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the impact of the Justice Department serving the Federal Reserve with grand jury subpoenas and threatening criminal indictment...
Fundsmith Equity Fund’s Thoughts on Novo Nordisk (NVO)
Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here.
Here’s Why SGA U.S. Large Cap Growth Strategy Sold Novo Nordisk (NVO)
Sustainable Growth Advisers (SGA), an investment management company, released its third-quarter investor letter for its “U.S.
Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)'s Weight Loss Pill
Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and Drug Administration’s (FDA) approval for its weight loss pill.
Here’s Why Novo Nordisk (NVO) Traded Down in Q3
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its third-quarter 2025 investor letter for the “Baird Chautauqua International and Global...
10 Stocks on Jim Cramer's Radar
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the latest figures for GDP growth.
Where is Novo Nordisk A/S (NVO) Headed?
Novo Nordisk A/S (NYSE:NVO) is one of the best affordable healthcare stocks to buy now.
10 Best Affordable Healthcare Stocks to Buy Now
According to him, this has been a year where certain areas of healthcare, particularly those related to health spend or real significant turnarounds in business, have performed pretty well, allowing certain...
Hedge Fund Resource Center Billionaire Hedge Funds
